Careers
ExploreTezacaftor and Ivacaftor - Information
Tezacaftor and Ivacaftor tablets in combination therapy and ivacaftor as a monotherapy are prescribed in patients 12 years and older who are suffering from cystic fibrosis (CF). The condition is due to one or two F508del mutations in the cystic fibrosis transmembrane conductance regulator (CFTR)
